Peptides
Peptide Therapeutics:
Precision Drug Delivery
Peptide therapeutics represent one of the fastest-growing classes of modern medicines, combining the specificity of biologics with the efficiency of small-molecule drugs.
Today, more than 80 peptide drugs are FDA approved, and the global peptide therapeutics market is projected to exceed USD 50 billion by 2030.
Peptides are short chains of amino acids that can be engineered to target specific biological pathways, allowing for highly selective treatments with improved safety profiles.
At VAi, our peptide platform focuses on the development and manufacturing of peptide medicines designed for targeted therapeutic action and precision drug delivery.
Key Focus Areas
Our peptide pipeline focuses on therapies addressing major health challenges in Africa, including:
- Chronic disease management
- Anti-infective therapies for drug-resistant bacteria and viruses
- Metabolic disorders such as Type 2 diabetes
- Non-opioid solutions for chronic pain relief
Peptide medicines offer several advantages including:
- High biological specificity
- Reduced systemic toxicity
- Ability to mimic naturally occurring biological molecules
Through local research and production, we aim to expand access to next-generation peptide medicines across Africa.